Human immunodeficiency virus type 1 protease regulation of Tat activity is essential for efficient reverse transcription and replication

Journal of Virology

Volumn 77, Issue 18, 2003, Pages 9912-9921

  Apolloni, Ann ^a,b,e   Hooker, C William ^a,b   Mak, Johnson ^c,d   Harrich, David ^a,b,e  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b HIV Virology Research   (Australia)

^c BURNET INSTITUTE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; HYBRID PROTEIN; POL PROTEIN; PROTEINASE; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETICULOCYTE LYSATE; REVERSE TRANSCRIPTION; TRANSACTIVATION; VIRUS REPLICATION;

ANIMALS; CELL LINE; GENE PRODUCTS, TAT; HIV PROTEASE; HIV-1; HUMANS; RABBITS; RETICULOCYTES; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 0141458953     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.18.9912-9921.2003     Document Type: Article

References (27)

1. Bayer, P., M. Kraft, A. Ejchart, M. Westendorp, R. Frank, and P. Rosch. 1995. Structural studies of HIV-1 Tat protein. J. Mol. Biol. 247:529-535.
2. Brand, S. R., R. Kobayashi, and M. B. Mathews. 1997. The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J. Biol. Chem. 272:8388-8395.
3. Bres, V., R. Kiernan, S. Emillani, and M. Benkirane. 2002. Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication. J. Biol. Chem. 277:22215-22221.
4. Col, E., C. Caron, D. Seigneurin-Berny, J. Gracia, A. Favier, and S. Khochbin. 2001. The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat. J. Biol. Chem. 276:28179-28184.
5. Demarchi, F., M. I. Gutierrez, and M. Giacca. 1999. Human immunodeficiency virus type 1 Tat protein activates transcription factor NF-κB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR. J. Virol. 73:7080-7086.
6. Gotte, M., X. Li, and M. A. Wainberg. 1999. HIV-1 reverse transcription: a brief overview focused on structure-function relationships among molecules involved in initiation of the reaction. Arch. Biochem. Biophys. 365:199-210.
7. Harrich, D., and B. Hooker. 2002. Mechanistic aspects of HIV-1 reverse transcription initiation. Rev. Med. Virol. 12:31-45.
8. Harrich, D., C. Hsu, E. Race, and R. B. Gaynor. 1994. Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants. J. Virol. 68:5899-5910.
9. Harrich, D., C. Ulich, L. F. Garcia-Martinez, and R. B. Gaynor. 1997. Tat is required for efficient HIV-1 reverse transcription. EMBO J. 16:1224-1235.
10. Hill, M. K., C. W. Hooker, D. Harrich, S. M. Crowe, and J. Mak. 2001. Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1. J. Virol. 75:6835-6840.
11. Hooker, C. W., W. B. Lott, and D. Harrich. 2001. Inhibitors of human immunodeficiency virus type 1 reverse transcriptase target distinct phases of early reverse transcription. J. Virol. 75:3095-3104.
12. Hooker, C. W., J. Scott, A. Apolloni, E. Parry, and D. Harrich. 2002. Human immunodeficiency virus type 1 reverse transcription is stimulated by tat from other lentiviruses. Virology 300:226-235.
13. Huang, L. M., A. Joshi, R. Willey, J. Orenstein, and K. T. Jeang. 1994. Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J. 13:2886-2896.
14. Kameoka, M., M. Morgan, M. Binette, R. S. Russell, L. Rong, X. Guo, A. Mouland, L. Kleiman, C. Liang, and M. A. Wainberg. 2002. The Tat protein of human immunodeficiency virus type 1 (HIV-1) can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription. J. Virol. 76:3637-3645.
15. Kameoka, M., L. Rong, M. Gotte, C. Liang, R. S. Russell, and M. A. Wainberg. 2001. Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication. J. Virol. 75:2675-2683.
16. Kiernan, R. E., C. Vanhulle, L. Schiltz, E. Adam, H. Xiao, F. Maudoux, C. Calomme, A. Burny, Y. Nakatani, K. T. Jeang, M. Benkirane, and C. Van Lint. 1999. HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J. 18:6106-6118.
17. McMillan, N. A., R. F. Chun, D. P. Siderovski, J. Galabru, W. M. Toone, C. E. Samuel, T. W. Mak, A. G. Hovanessian, K. T. Jeang, and B. R. Williams. 1995. HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology 213:413-424.
18. Mowen, K. A., J. Tang, W. Zhu, B. T. Schurter, K. Shuai, H. R. Herschman, and M. David. 2001. Arginine methylation of STAT1 modulates IFNalpha/beta-induced transcription. Cell 104:731-741.
19. Ott, M., M. Schnolzer, J. Garnica, W. Fischle, S. Emiliani, H. R. Rackwitz, and E. Verdin. 1999. Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr. Biol. 9:1489-1492.
20. Peloponese, J. M., Jr., C. Gregoire, S. Opi, D. Esquieu, J. Sturgis, E. Lebrun, E. Meurs, Y. Collette, D. Olive, A. M. Aubertin, M. Witvrow, C. Pannecouque, E. De Clercq, C. Bailly, J. Lebreton, and E. P. Loret. 2000. 1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein. C. R. Acad. Sci. Ser. III 323:883-894.
21. Stauber, R. H., and G. N. Pavlakis. 1998. Intracellular trafficking and interactions of the HIV-1 Tat protein. Virology 252:126-136.
22. Ulich, C., A. Dunne, E. Parry, C. W. Hooker, R. B. Gaynor, and D. Harrich. 1999. Functional domains of Tat required for efficient human immunodeficiency virus type 1 reverse transcription. J. Virol. 73:2499-2508.
23. Ulich, C., D. Harrich, P. Estes, and R. B. Gaynor. 1996. Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins. J. Virol. 70:4871-4876.
24. Verhoef, K., M. Koper, and B. Berkhout. 1997. Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication. Virology 237:228-236.
25. Verhoef, K., G. Marzio, W. Hillen, H. Bujard, and B. Berkhout. 2001. Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J. Virol. 75:979-987.
26. Verhoef, K., M. Tijms, and B. Berkhout. 1997. Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin. Nucleic Acids Res. 25:496-502.
27. Zybarth, G., H. G. Krausslich, K. Partin, and C. Carter. 1994. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain. J. Virol. 68:240-250.